ACET - Adicet Bio, Inc.
7.02
-0.270 -3.846%
Share volume: 111,260
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$7.29
-0.27
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-06-2024 | 03-06-2025 | 05-06-2025 | 08-07-2025 | 11-05-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 30.871 M | 32.849 M | 33.153 M | 0.000 | 29.885 M | 32.392 M | 27.952 M | |
| Selling general and admin | 6.974 M | 6.948 M | 6.900 M | 0.000 | 7.071 M | 3.968 M | 5.099 M | |
| Research and development | 23.897 M | 25.901 M | 26.253 M | 0.000 | 22.814 M | 28.424 M | 22.853 M | |
| Total expenses | 30.871 M | 32.849 M | 33.153 M | 0.000 | 29.885 M | 32.392 M | 27.952 M | |
| 6.41% | 0.93% | -100.00% | 8.39% | -13.71% | ||||
| Operating income | -30.871 M | -32.849 M | -33.153 M | 0.000 | -29.885 M | -32.392 M | -27.952 M | |
| Ebit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Pretax income | -28.016 M | -29.901 M | -30.478 M | 0.000 | -28.214 M | -31.217 M | -26.856 M | |
| 6.73% | 1.93% | -100.00% | 10.64% | -13.97% | ||||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -28.016 M | -29.901 M | -30.478 M | 0.000 | -28.214 M | -31.217 M | -26.856 M | |
| -6.73% | -1.93% | 100.00% | -10.64% | 13.97% |